• Deals this week: Olon SpA, MannKind, Shire pharmaceutical-technology
    September 11, 2018
    Olon SpA has agreed to purchase an active pharmaceutical ingredient (API) manufacturing plant located in Mahad, India, from Novartis for an undisclosed sum.
PharmaSources Customer Service